Categories AlphaGraphs, Earnings, Health Care
HUM Earnings: Highlights of Humana’s Q4 2022 financial results
Humana Inc. (NYSE: HUM) on Wednesday reported fourth-quarter 2022 results. Adjusted profit increased from last year, aided by a 7% growth in revenues.
On an unadjusted basis, the company reported a net loss of $15 million or $0.12 per share for the December quarter, compared to a loss of $14 million or $0.11 per share a year ago. Excluding special items, it posted net earnings of $1.62 per share for the three-month period, up 31% year-over-year.
Total revenues increased by 7% to $22.4 billion in the fourth quarter. The management expects full-year 2023 earnings to be at least $27.57 per share on an unadjusted basis, and around $28.00 per share on an adjusted basis
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
